Literature DB >> 10959943

Creutzfeldt-Jakob disease in health professionals in Slovakia.

E Mitrová1, G Belay.   

Abstract

Creutzfeldt-Jakob disease (CJD) is the most important human transmissible spongiform encephalopathy (prion disease), recognised in sporadic, genetic but also iatrogenic forms. The identification of 8 health care workers in a group of 114 definitive CJD patients in Slovakia suggested the possibility of professionally acquired CJD and induced the investigation of potential endo- and exogenous risk factors. In CJD-affected health professionals special attention was paid to a detailed occupational history, including a possible professional contact with CJD patient and to the findings characteristic for iatrogenic CJD: early cerebellar symptomatology, long duration of the disease, absence of typical EEG finding and homozygosity of PRNP gene at codon 129. Analysis of epidemiological, clinical and molecular biological data in investigated group of CJD-affected health professionals gave no evidence of an occupational risk for CJD.

Entities:  

Mesh:

Year:  2000        PMID: 10959943     DOI: 10.1023/a:1007601313133

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

Review 1.  Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews.

Authors:  Z Meiner; R Gabizon; S B Prusiner
Journal:  Medicine (Baltimore)       Date:  1997-07       Impact factor: 1.889

2.  New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests.

Authors:  M Zeidler; G E Stewart; C R Barraclough; D E Bateman; D Bates; D J Burn; A C Colchester; W Durward; N A Fletcher; S A Hawkins; J M Mackenzie; R G Will
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

3.  Some new aspects of CJD epidemiology in Slovakia.

Authors:  E Mitrová
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

4.  "Clusters" of CJD in Slovakia: the first statistically significant temporo-spatial accumulations of rural cases.

Authors:  E Mitrová; M Bronis
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

5.  Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia.

Authors:  L G Goldfarb; E Mitrová; P Brown; B K Toh; D C Gajdusek
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

6.  Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.

Authors:  T K Koch; B O Berg; S J De Armond; R F Gravina
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

7.  Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families.

Authors:  L G Goldfarb; P Brown; E Mitrovà; L Cervenáková; L Goldin; A D Korczyn; J Chapman; S Gálvez; L Cartier; R Rubenstein
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

Review 8.  Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers.

Authors:  J R Berger; N J David
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

9.  Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine.

Authors:  P Brown; L Cervenáková; L G Goldfarb; W R McCombie; R Rubenstein; R G Will; M Pocchiari; J F Martinez-Lage; C Scalici; C Masullo
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

10.  Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).

Authors:  C M van Duijn; N Delasnerie-Lauprêtre; C Masullo; I Zerr; R de Silva; D P Wientjens; J P Brandel; T Weber; V Bonavita; M Zeidler; A Alpérovitch; S Poser; E Granieri; A Hofman; R G Will
Journal:  Lancet       Date:  1998-04-11       Impact factor: 79.321

View more
  1 in total

1.  Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993-2018.

Authors:  Peter Hermann; Johannes Treig; Steffen Unkel; Stefan Goebel; Timothy Bunck; Martha Jünemann; Tim Friede; Inga Zerr
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.